WI
HZNP

Wahed Invest’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Wahed Invest’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,503
Closed -$405K – 262
2023
Q3 		$405K Buy
3,503
+274
+8% +$29.4K 0.13% 124
2023
Q2 		$332K Buy
3,229
+475
+17% +$50.1K 0.12% 142
2023
Q1 		$301K Sell
2,754
-46
-2% -$5.08K 0.13% 134
2022
Q4 		$319K Buy
2,800
+216
+8% +$17.9K 0.17% 119
2022
Q3 		$160K Buy
2,584
+184
+8% +$12.9K 0.1% 161
2022
Q2 		$191K Sell
2,400
-168
-7% -$15.9K 0.12% 143
2022
Q1 		$270K Sell
2,568
-43
-2% -$4.19K 0.16% 131
2021
Q4 		$281K Buy
+2,611
New +$285K 0.16% 128

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wahed Invest's HZNP Position: Q4 2023 in Review

Wahed Invest sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 3,503 shares — an estimated $405K sold.

Wahed Invest first reported a position in HZNP in Q4 2021 and held it in 8 quarters. The position peaked at $405K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Wahed Invest reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Wahed Invest sold 3,503 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $405K.
  • Wahed Invest first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 8 quarters.
  • Wahed Invest's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $405K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Wahed Invest's 13F filing for Q4 2023, filed 14 Feb 2024.